Hrt Financial LP Repare Therapeutics Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$8.16 - $13.01 $69,351 - $110,571	8,499 Added 59.29%	22,834 $275,000
Q2 2023 Aug 11, 2023	SELL	$8.63 - $12.53 $14,317 - $20,787	-1,659 Reduced 10.37%	14,335 $151,000
Q1 2023 May 12, 2023	SELL	$9.32 - $15.06 $60,906 - $98,417	-6,535 Reduced 29.01%	15,994 $157,000
Q4 2022 Feb 10, 2023	BUY	$12.5 - $18.13 $281,612 - $408,450	22,529 New	22,529 $331,000
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $310,653 - $425,804	-12,083 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$30.1 - $34.85 $363,698 - $421,092	12,083 New	12,083 $376,000
Q1 2021 May 17, 2021	SELL	$25.89 - $44.46 $509,592 - $875,106	-19,683 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.42 - $39.5 $460,975 - $777,478	19,683 New	19,683 $675,000

35.4M

51K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $48.2M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.